These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Leukotrienes on porcine hemodynamics and prostanoid release. Fiedler VB, Mardin M, Gardiner PJ, Abram TS. Int J Cardiol; 1985 Aug; 8(4):451-63. PubMed ID: 2993176 [Abstract] [Full Text] [Related]
8. Inhibition of leukotriene actions by the calcium channel blocker, nisoldipine. Lefer AM, Yanagisawa A. Proc Soc Exp Biol Med; 1986 Jul; 182(3):296-300. PubMed ID: 3012574 [Abstract] [Full Text] [Related]
9. Positive inotropic effects of low concentrations of leukotrienes C4 and D4 in rat heart. Karmazyn M, Moffat MP. Am J Physiol; 1990 Oct; 259(4 Pt 2):H1239-46. PubMed ID: 1699437 [Abstract] [Full Text] [Related]
10. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. Burke JA, Levi R, Guo ZG, Corey EJ. J Pharmacol Exp Ther; 1982 Apr; 221(1):235-41. PubMed ID: 6278136 [Abstract] [Full Text] [Related]
12. Effect of exogenous 5,8,11,14,17-eicosapentaenoic acid on cardiac anaphylaxis. Juan H, Peskar BA, Simmet T. Br J Pharmacol; 1987 Feb; 90(2):315-25. PubMed ID: 2881590 [Abstract] [Full Text] [Related]
13. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4. Piper PJ, Stewart AG. Br J Pharmacol; 1986 Jul; 88(3):595-605. PubMed ID: 3091131 [Abstract] [Full Text] [Related]
14. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Michelassi F, Landa L, Hill RD, Lowenstein E, Watkins WD, Petkau AJ, Zapol WM. Science; 1982 Aug 27; 217(4562):841-3. PubMed ID: 6808665 [Abstract] [Full Text] [Related]
15. Cardiac actions of leukotrienes B4, C4, D4, and E4 in guinea pig and rat in vitro. Letts LG, Piper PJ. Adv Prostaglandin Thromboxane Leukot Res; 1983 Aug 27; 11():391-5. PubMed ID: 6303075 [No Abstract] [Full Text] [Related]
16. Coronary vasoconstriction induced by leukotrienes in the anaesthetized dog. Woodman OL, Dusting GJ. Eur J Pharmacol; 1982 Dec 17; 86(1):125-8. PubMed ID: 6297922 [Abstract] [Full Text] [Related]
17. Potentiation of leukotriene formation in pulmonary and vascular tissue. Lefer AM, Roth DM, Lefer DJ, Smith JB. Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun 17; 326(2):186-9. PubMed ID: 6089002 [Abstract] [Full Text] [Related]
18. The synthesis, release and action of leukotrienes in the isolated, unstimulated, buffer-perfused rat heart. Garlick PB, Mashiter GD, Di Marzo V, Tippins JR, Morris HR, Maisey MN. J Mol Cell Cardiol; 1989 Nov 17; 21(11):1101-10. PubMed ID: 2607544 [Abstract] [Full Text] [Related]
19. [Effect of leukotriene E4 on the central hemodynamics and vascular contractile activity]. Gabrielian ES, Akopov SE, Melik-Israelian ShS, Erzinkian SM, Tolstikov AG. Biull Eksp Biol Med; 1986 Apr 17; 101(4):438-40. PubMed ID: 3008879 [Abstract] [Full Text] [Related]
20. Antagonism of thromboxane actions in the isolated perfused rat heart. Stahl GL, Darius H, Lefer AM. Life Sci; 1986 Jun 02; 38(22):2037-41. PubMed ID: 2940431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]